News | April 11, 2025
Granules India completes acquisition of Senn Chemicals
Strengthening capabilities in Peptide Therapeutics and CDMO services
Strengthening capabilities in Peptide Therapeutics and CDMO services
Positions Curium as leading manufacturer of Lu-177 isotope
The new site will increase Syngene's total single-use bioreactor capacity to 50,000L
In 2023, Endox had revenues of approximately SEK 65 million
The transaction is part of a broader agreement with Bureau Veritas covering its worldwide food laboratory testing activities
Acquisition adds potential best-in-class disease-modifying therapy for Alzheimer's disease
Potential to optimize and build on the synergies in commercial operations, distribution, manufacturing, supply chain etc.
The transaction involves the acquisition of 100% shareholding of Bharat Serums and Vaccines (BSV) by Mankind Pharma
The acquisition of LumiraDx’s Point of Care technology received all required antitrust and regulatory clearances
Emraclidine, a potential best-in-class, next-generation antipsychotic, is in trials designed to be registration enabling for schizophrenia
Subscribe To Our Newsletter & Stay Updated
